Mutation in KERA identified by linkage analysis and targeted resequencing in a pedigree with premature atherosclerosis.

Maiwald, Stephanie; Sivapalaratnam, Suthesh; Motazacker, Mahdi M; van Capelleveen, Julian C; Bot, Ilze; de Jager, Saskia C; van Eck, Miranda; Jolley, Jennifer; Kuiper, Johan; Stephens, Jonathon; Albers, Cornelius A; Vosmeer, C Ruben; Kruize, Heleen; Geerke, Daan P; van der Wal, Allard C; van der Loos, Chris M; Kastelein, John J P; Trip, Mieke D; Ouwehand, Willem H; Dallinga-Thie, Geesje M; Hovingh, G Kees

Maiwald, Stephanie; Sivapalaratnam, Suthesh; Motazacker, Mahdi M; van Capelleveen, Julian C; Bot, Ilze; de Jager, Saskia C; van Eck, Miranda; Jolley, Jennifer; Kuiper, Johan; Stephens, Jonathon; Albers, Cornelius A; Vosmeer, C Ruben; Kruize, Heleen; Geerke, Daan P; van der Wal, Allard C; van der Loos, Chris M; Kastelein, John J P; Trip, Mieke D; Ouwehand, Willem H; Dallinga-Thie, Geesje M; Hovingh, G Kees.

Affiliation

Maiwald S; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Sivapalaratnam S; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Motazacker MM; Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
van Capelleveen JC; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Bot I; Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands; Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
de Jager SC; Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands; Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
van Eck M; Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands; Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Jolley J; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge, United Kingdom.
Kuiper J; Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden, the Netherlands; Department of Human Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.
Stephens J; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge, United Kingdom.
Albers CA; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge, United Kingdom.
Vosmeer CR; Amsterdam Institute of Molecules, Medicines and Systems, Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, VU University, Amsterdam, the Netherlands.
Kruize H; Amsterdam Institute of Molecules, Medicines and Systems, Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, VU University, Amsterdam, the Netherlands.
Geerke DP; Amsterdam Institute of Molecules, Medicines and Systems, Division of Molecular and Computational Toxicology, Department of Chemistry and Pharmaceutical Sciences, VU University, Amsterdam, the Netherlands.
van der Wal AC; Department of Pathology, Academic Medical Centre, Amsterdam, the Netherlands.
van der Loos CM; Department of Pathology, Academic Medical Centre, Amsterdam, the Netherlands.
Kastelein JJ; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Trip MD; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Ouwehand WH; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; National Health Service Blood and Transplant, Cambridge, United Kingdom.
Dallinga-Thie GM; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands; Department of Experimental Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.
Hovingh GK; Department of Vascular Medicine, Academic Medical Centre, Amsterdam, the Netherlands.

PLoS One ; 9(5): e98289, 2014.

Article de En | MEDLINE | ID: mdl-24879339

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pedigree / Protéoglycanes / Analyse de mutations d'ADN / Athérosclérose / Liaison génétique / Mutation Type d'étude: Prognostic_studies Limites: Aged / Animals / Female / Humans / Male / Middle aged Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2014 Type de document: Article Pays d'affiliation: Pays-Bas Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google